Clinical Trial Update: To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing combination therapy with B55R1 and B55R2 versus B55R1 alone in non-proliferative diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• B55R1 (B55R1)
• B55R2 (B55R2)

Snippet

Sponsor: AJU Pharm Co., Ltd. | Conditions: Non-Proliferative Diabetic Retinopathy | Phase 4 | Status: COMPLETED